New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 11, 2014
11:31 EDTINO, SD, CREE, GNC, OREX, WTW, INVN, UBNT, AEGR, SANOptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
News For INO;AEGR;UBNT;INVN;WTW;OREX;GNC;CREE;SD;SAN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 22, 2014
07:42 EDTCREECree downgraded to Neutral from Buy at DA Davidson
Subscribe for More Information
07:35 EDTAEGRCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
05:56 EDTCREECree downgraded to Hold from Buy at Canaccord
Subscribe for More Information
October 21, 2014
18:36 EDTCREEOn The Fly: After Hours Movers
Subscribe for More Information
16:03 EDTCREECree sees Q2 EPS 20c-24c, consensus 39c
Subscribe for More Information
16:02 EDTCREECree reports Q1 adjusted EPS 24c, consensus 36c
Subscribe for More Information
15:30 EDTCREENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Yahoo! (YHOO), consensus 30c; ACE (ACE), consensus $2.34; Discover Financial (DFS), consensus $1.34; Pinnacle Financial (PNFP), consensus 51c; Broadcom (BRCM), consensus 84c; Intuitive Surgical (ISRG), consensus $3.80; FMC Technologies (FTI), consensus 74c; Robert Half International (RHI), consensus 58c; E-Trade (ETFC), consensus 22c; Nabors Industries (NBR), consensus 36c; Waste Connections (WCN), consensus 54c; Cubist Pharmaceuticals (CBST), consensus 4c; Sonic (SONC), consensus 34c; American Campus Communities (ACC), consensus 43c; Cree (CREE), consensus 36c; Fulton Financial (FULT), consensus 20c; Costamare (CMRE), consensus 41c; Hawaiian Holdings (HA), consensus 78c; Ethan Allen (ETH), consensus 36c; Sabra Health (SBRA), consensus 55c; Rush Enterprises (RUSHA), consensus 51c.
15:25 EDTCREEEarnings Preview: Cree reports after pre-announcing Q1 miss
Subscribe for More Information
14:04 EDTINVNEarnings Preview: Analysts divided on Broadcom ahead of Q3 report
Subscribe for More Information
13:39 EDTCREECree technical comments ahead of earnings
Subscribe for More Information
13:06 EDTCREECree October weekly 33 straddle priced for 8.2% move into Q1
09:12 EDTGNCGNC, eBay, Vivendi recommended as long ideas by Sandler, Bloomberg reports
Subscribe for More Information
08:18 EDTSANBasel Committee accelerating work on leverage ratio, FT says
The Basel Committee on Banking Supervision will begin work on the calibration of the leverage ratio, a measure of bank capital seen as less vulnerable to manipulation, sooner than previously planned, which suggests the finished rule could be released as soon as 2015 or 2016, which is ahead of the previous target date of 2017, reported Financial Times, citing comments from the secretary-general of the committee, William Coen. Publicly traded large U.S. banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Publicly traded large EU banks include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), Royal Bank of Scotland (RBS) and UBS (UBS). Reference Link
06:10 EDTINOInovio, MedImmune, UPENN awarded $12.2M collaborative study by DARPA
Inovio Pharmaceuticals (INO) announced the Defense Advanced Research Projects Agency, or DARPA, has awarded $12.2M for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research and development arm of AstraZeneca (AZN). The group will develop DNA-based monoclonal antibodies, or mAbs, for infectious disease treatment. DARPA is an agency of the US Department of Defense that creates and supports novel technologies important for national security. Together, the three organizations will develop and assess the DNA mAbs in preclinical studies using technology developed by Penn and licensed by Inovio. The collaboration will focus on three disease areas influenza virus, Pseudomonas aeruginosa and Staphylococcus aureus.
October 20, 2014
14:46 EDTGNCVitamin Shoppe may hire adviser amid pressure for deal, Reuters says
Vitamin Shoppe (VSI), which has been urged by activist shareholders to consider a sale, is speaking to banks and may hire a financial adviser, according to Reuters, citing people familiar with the matter. Note that Reuters previously reported on September 18 that some large Vitamin Shoppe holders have urged the company to consider a sale to rival GNC Holdings (GNC) or to a private equity buyer. That same day, The Financial Times reported that GNC was considering a possible sale after receiving attention from private equity suitors. Following this latest report from Reuters, shares of Vitamin Shoppe are up 6.7% to $45.23 in afternoon trading, while GNC shares are up over 3% to $38.88. Reference Link
08:08 EDTOREXOrexigen and Takeda announce availability of Contrave tablets for patients
Takeda Pharmaceutical, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A. and Orexigen Therapeutics jointly announced that Contrave extended-release tablets are now available to patients by prescription in pharmacies across the U.S.. Contrave is approved by the FDA as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater, or 27 kg/m2 or greater in the presence of at least one weight-related comorbid condition.
07:24 EDTAEGRAegerion price target lowered to $46 from $66 at Leerink
Leerink lowered its price target for Aegerion shares to $46 after its survey of 40 U.S. cardiologists implied a more bearish outlook for Juxtapid once PCSK9s emerge. The firm, however, believes new patient adds are well outpacing Juxtapid discontinuations in the near term. It keeps an Outperform rating on the stock.
05:54 EDTSDStocks with implied volatility movement; HLD SD
Stocks with implied volatility movement; Herbalife (HLF) 109, SandRidge Energy (SD) 97 according to iVolatility.
October 17, 2014
06:28 EDTCREEIHS: LED smart bulb shipments to surpass 11M units in 2018, DigiTimes says
LED smart bulb shipments is expected to reach more than 11M units in 2018, reports DigiTimes, citing the IHS. Approximately 880,000 connected LED smart bulbs were shipped globally in 2013. Reference Link
05:51 EDTSD, SANStocks with implied volatility movement; SD SAN
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use